You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Investigational Drug Information for Tricaprilin


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Tricaprilin?

Tricaprilin is an investigational drug.

There have been 14 clinical trials for Tricaprilin. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2024.

The most common disease conditions in clinical trials are Alzheimer Disease, Spasm, and Migraine Disorders. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].

There are one hundred and twenty-three US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Tricaprilin
TitleSponsorPhase
Tricaprilin Phase 3 AD StudyCerecinPhase 3
AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing ConditionsCerecinPhase 1
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy SubjectsCerecinPhase 1

See all Tricaprilin clinical trials

Clinical Trial Summary for Tricaprilin

Top disease conditions for Tricaprilin
Top clinical trial sponsors for Tricaprilin

See all Tricaprilin clinical trials

US Patents for Tricaprilin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tricaprilin ⤷  Sign Up Ammonia oxidizing bacteria for treatment of eczema AOBIOME LLC (Cambridge, MA) ⤷  Sign Up
Tricaprilin ⤷  Sign Up Easily formulated zinc oxide powder BASF SE (Ludwigshafen, DE) ⤷  Sign Up
Tricaprilin ⤷  Sign Up Treatments for resistant acne VYOME BIOSCIENNCES PVT. LTD. (New Delhi, IN) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.